Infectious Disease Control

Brii Bio Appoints Coy Stout as Senior Vice President and Head of U.S. Market Access and Patient Advocacy

DURHAM, N.C. and BEIJING, Sept. 28, 2021 /PRNewswire/ -- Brii Biosciences Limited ("Brii Bio" or the "Company", stock code: 2137.HK) a multi-national company developing innovative therapies for diseases with significant unmet medical needs and large public heal...

2021-09-28 08:00 5876

LEAD Horizon: How travelers in Austria gargle against the corona virus

Austrian success model with gold standard tests is possible worldwide VIENNA, Sept. 27, 2021 /PRNewswire/ -- Vienna got through the pandemic better in comparison to other European cities - thanks to a specially developed PCR test by the Austrian company LEAD Horizon, which is already used in 13 ...

2021-09-27 09:00 3468

Kintor Pharma Announces Brazil's ANVISA Approves Phase III Clinical Trial of Proxalutamide for the Treatment of Hospitalized COVID-19 Patients

SUZHOU, China, Sept. 26, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, today announced that onSeptember 22 the Brazilian Health Regulatory Agency (ANVISA) ...

2021-09-26 23:09 6469

Results from Novavax NanoFlu Influenza Vaccine Phase 3 Clinical Trial Published in The Lancet Infectious Diseases

- Pivotal Phase 3 trial achieved all primary endpoints, demonstrating non-inferiority to a leading U.S.-licensed quadrivalent influenza vaccine - NanoFlu™ vaccine candidate induced significantly enhanced cell-mediated immune responses - NanoFlu was well-tolerated with a comparable safety profile...

2021-09-24 08:47 6068

/C O R R E C T I O N -- pHOXBIO/

In the news release, pHOXBIO Announces Breakthrough Clinical Trial Results Concluding Prophylactic Nasal Spray Prevents Infection from SARS-CoV-2, issued Sept. 22, 2021 by pHOXBIO over PR Newswire, we are advised by the company that the hyperlinks have been revised. The complete, corrected releas...

2021-09-24 02:42 2876

Novavax and Serum Institute of India Announce Submission to World Health Organization for Emergency Use Listing of Novavax' COVID-19 Vaccine

* Novavax and Serum Institute of India file regulatory submission for World Health Organization Emergency Use Listing of Novavax' recombinant nanoparticle protein-based COVID-19 vaccine GAITHERSBURG, Md., Sept. 23, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedic...

2021-09-23 21:59 8047

BioVaxys Prepares for Groundbreaking Study on reduced ACE2 binding capabilities of Hapten-modified SARS-CoV-2 proteins

- Potential for superior tolerability to mRNA and Adenovirus Vector vaccines - Production Agreement signed with Millipore-Sigma for SARS-CoV-2 Vaccine Supply VANCOUVER, BC, Sept. 23, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company"), a...

2021-09-23 15:00 6776

INOVIO Receives Regulatory Authorization to Conduct Phase 3 Efficacy Trial of its COVID-19 DNA Vaccine Candidate, INO-4800, in Mexico

News follows recent regulatory authorizations to proceed with the trial in Brazil and the Philippines INOVIO and partner Advaccine are collaborating on the global Phase 3 trial in regions underserved by COVID-19 vaccines; to focus onLatin America, Asia, and Africa PLYMOUTH MEETING, Pa., Sept. 2...

2021-09-22 20:00 6323

Clover's COVID-19 Vaccine Candidate Demonstrates 79% Efficacy Against Delta in Global Phase 2/3 SPECTRA Trial Dominated by Variants of Concern and Interest

* Trial enrolled over 30,000 adult & elderly participants across 4 continents; 100% of SARS-CoV-2 strains observed in efficacy analysis were variants (Delta was predominant strain) * Primary and secondary efficacy endpoints were successfully met * 100% efficacy against severe COVID-19 & hosp...

2021-09-22 18:56 2808

Significantly Improved Safety Profile and Metabolism of Remdesivir Observed Due to Encapsulation in NanoViricides Drug Candidate Enabling Potential Highly Effective Pan-Coronavirus Antiviral Drug

SHELTON, Conn., Sept. 22, 2021 /PRNewswire/ -- NanoViricides, Inc. (NYSE American: NNVC) (the "Company"), a leader in the development of highly effective antiviral therapies based on a novel nanomedicines technology, reported today on the significant advantages gained by remdesivir encapsulation ...

2021-09-22 18:45 6237

The International Standard Proposed by Experts from BMC Medical in Terms of High-flow Respiratory Therapy Equipment Officially Released

BEIJING, Sept. 22, 2021 /PRNewswire/ -- The international standard for high-flow respiratory therapy equipment (standard number: ISO 80601-2-90:2021) proposed by BMC Medical standardization technical experts has been formally released recently on the official websites of the International Organiz...

2021-09-22 15:00 3589

FII Institute Launches Global Infectious Diseases Index

FII Institute launched a unique global index that uses groundbreaking technology to track infectious diseases and transform how the world reacts to future crises. The Global Infectious Diseases Index was developed by FII Institute in partnership with Accenture and Metabiota. Metabiota's risk so...

2021-09-21 23:19 3983

Novavax to Participate in Fireside Chat at Devex @ UNGA 76

GAITHERSBURG, Md., Sept. 21, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing and commercializing next-generation vaccines for serious infectious diseases, today announced thatJohn J. Trizzino, Executive Vice President, Chief Commercial Officer and Chief Busin...

2021-09-21 04:46 8348

P&G partners with Philippine Red Cross for COVID-19 Bakuna Buses in CALABARZON

MANILA, Philippines, Sept. 20, 2021 /PRNewswire/ -- Procter & Gamble (P&G) Philippines continues stepping up as a force for good by supporting the Philippine Red Cross (PRC) mission to assist in the government's national COVID-19 vaccination program.

2021-09-20 15:09 3240

Experts Call on World Leaders to Commit to a Global Plan of Attack on COVID at Summit

More Than 60 Leading Organizations Across Civil Society, Academia, Philanthropy, Health, and Social Enterprise Define a 6-Point Plan to End the Global COVID-19 Crisis SEATTLE, Sept. 20, 2021 /PRNewswire/ -- This week, hosted by the United States , world leaders will gather virtually for theGlobal...

2021-09-20 12:00 2684

New Zealand's Cancer Organisations Warn Of COVID Pandemic-led Drop In Cancer Being Diagnosed And Treated

* Growing concern that people are reluctant to see their doctor about troubling symptoms during current uncertain period. This follows last year's lockdown which saw a decline in diagnosis of cancer across Aotearoa.[1]  * Around 9,000 New Zealanders die of cancer every year.[2]  * New campai...

2021-09-20 06:00 2289

SARS-CoV-2, Influenza A inactivated by zinc-embedded nylon fabric

A paper published in ACS Applied Materials Interfaces details effectiveness, describes protocol for future testing HOUSTON, Sept. 18, 2021 /PRNewswire/ -- An international team of scientists and engineers from theUniversity of Cambridge, the Icahn School of Medicine at Mount Sinai, ResInnova Lab...

2021-09-18 04:53 5692

COVID-19 Scoop: Epoch-Making GoldenBiotech's Oral COVID-19 New Drug Trial Got Green Light from the FDA to Extend Recruiting Severe COVID-19 Patients

TAIPEI, Sept.16, 2021 /PRNewswire/ -- Golden Biotechnology Corp.(TPEx:4132) ("GoldenBiotech", GBC), a leading Taiwanese biopharmaceutical company, announces that its oral investigational new drug Antroquinonol (HOCENA®) has made headway withCOVID-19 treatment development in more broaden clinical ...

2021-09-16 18:05 2705

Key milestone: DHL delivers 1 billion COVID-19 vaccine doses

* 1 billion vaccine doses shipped to more than 160 countries in the fight against COVID-19 sinceDecember 2020 * Smooth management and execution of different supply chain set-ups * Planning essential to identify and prevent future health emergencies SINGAPORE, Sept. 16, 2021 /PRNewswire/ -- C...

2021-09-16 16:00 16502

Sputnik V Demonstrates 97.2% Efficacy And High Safety Profile Against COVID During The Vaccination Campaign In Belarus

MOSCOW, Sept. 15, 2021 /PRNewswire/ -- The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) announces the real world data of the Ministry of Health of theRepublic of Belarus on the Russian Sputnik V coronavirus vaccine confirming its high efficacy during the vaccination campai...

2021-09-15 16:00 1909
1 ... 26272829303132 ... 35